StatOrigin open statistical archive
Industries Indicators Regions Rankings Reports Compare Sources

Common new active substance approvals across major regulatory authorities (multi-year total)

Total count of new active substances approved across all designated major regulatory authorities during the period.

Unit Count Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
2
Regions
1
Period
2016–2025
Sources
1
Verification 2 verified data points Verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

Over time

Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Common new active substance approvals across major regulatory authorities (multi-year total)

Global, 2016–2020 to 2021–2025

2 observations · 2016–2020 to 2021–2025
Common new active substance approvals across major regulatory authorities (multi-year total)Common new active substance approvals across major regulatory authorities (multi-year total). 2 observations from 2016–2020 to 2021–2025, ranging from 37 to 52. Latest value 52 (2021–2025). 0 10 20 30 40 50 60 2016 2017 2018 2019 2020 2021 37 52
Common new active substance approvals across major regulatory authorities (multi-year total)Common new active substance approvals across major regulatory authorities (multi-year total). 2 observations from 2016–2020 to 2021–2025, ranging from 37 to 52. Latest value 52 (2021–2025). 0 20 40 60 2016 2017 2018 2019 2020 2021 37 52
Common new active substance approvals across major regulatory authorities (multi-year total)Common new active substance approvals across major regulatory authorities (multi-year total). 2 observations from 2016–2020 to 2021–2025, ranging from 37 to 52. Latest value 52 (2021–2025). 0 20 40 60 2016 2017 2018 2019 2020 2021 37 52
View the underlying data
Common new active substance approvals across major regulatory authorities (multi-year total)
Period Type Value
2016–2020 Actual 37
2021–2025 Actual 52
Source: CIRS · count · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/pharmaceuticals--common-new-active-substance-approvals-across-major-regulatory-authorities-multi---trend" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Common new active substance approvals across major regulatory authorities (multi-year total)" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/common-new-active-substance-approvals-across-major-regulatory-authorities-multi-">Common new active substance approvals across major regulatory authorities (multi-year total)</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

2 records · 1 region · 2016–2025

Download CSV JSON series
Common new active substance approvals across major regulatory authorities (multi-year total): every record, grouped by region, newest first.
Period Value Source Type
Global 2 records
2021–2025 52 CIRS · 31 Dec 2025 actual
2016–2020 37 CIRS · 31 Dec 2020 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
New Drug Approvals by Six Major Authorities 2016-2025 CIRS — 2

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Common new active substance approvals across major regulatory authorities (multi-year total). Retrieved from https://statorigin.org/indicators/common-new-active-substance-approvals-across-major-regulatory-authorities-multi-

Download CSV Get this data as JSON Compare with… API docs